Very Low Dose Danazol in Idiopathic Thrombocytopenic Purpura and its Role as an Immune Modulator
Open Access
- 1 October 1989
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 298 (4) , 215-220
- https://doi.org/10.1097/00000441-198910000-00002
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Low-Dose Danazol Therapy in Idiopathic Thrombocytopenic PurpuraAnnals of Internal Medicine, 1987
- Immune modulation by danazol in autoimmune thrombocytopeniaClinical Immunology and Immunopathology, 1987
- Effect of Danazol in Immune Thrombocytopenic PurpuraNew England Journal of Medicine, 1987
- A COMPARISON OF THE EFFECTS OF DANAZOL AND GESTRINONE ON TESTOSTERONE BINDING TO SEX HORMONE BINDING GLOBULIN IN VITRO AND IN VIVOClinical Endocrinology, 1986
- The cellular basis for the induction of antigen‐specific T8 suppressor cellsEuropean Journal of Immunology, 1986
- Interactions Between the Gonadal Steroids and the Immune SystemScience, 1985
- Danazol for the Treatment of Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1983
- Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures.The Journal of Experimental Medicine, 1981
- Glucocorticoids and immune responsesArthritis & Rheumatism, 1979
- Treatment of Idiopathic Thrombocytopenic Purpura (ITP)Annual Review of Medicine, 1977